: Expectation of survival of patients receiving HMA + VEN is influenced by pre-treatment comorbidity burden.
Marconi, G., Petracci, E., Lanzarone, G., Vetro, C., Martelli, M.P., Papayannidis, C., et al. (2025). Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents. AMERICAN JOURNAL OF HEMATOLOGY, Online ahead of print., 1-1 [10.1002/ajh.27591].
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents
Marconi, Giovanni
;Petracci, Elisabetta
;Papayannidis, Cristina;Martini, Gianluca;Vincenzo, Federico;Rondoni, Michela;Nanni, Jacopo;Zingaretti, Chiara;Lanza, Francesco;Curti, Antonio;Todisco, Elisabetta;Martinelli, Giovanni
2025
Abstract
: Expectation of survival of patients receiving HMA + VEN is influenced by pre-treatment comorbidity burden.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
